Monoclonal antibodies that selectively recognize methamphetamine and methamphetamine like compounds

Inventors

S. Michael OwensFollow
Melinda Gunnell
Yingni Chi
F. Ivy Carroll
Ralph Henry, University of Arkansas, FayettevilleFollow
Eric Peterson

Document Type

Patent

Publication Date

12-28-2010

Abstract

The invention generally relates to monoclonal antibodies that recognize at least one compound from the group consisting of (+) methamphetamine, (+) amphetamine, and (+) 3,4-methylenedioxymethamphetamine ((+) MDMA). Generally speaking, the monoclonal antibodies do not recognize (-) methamphetamine, (-) amphetamine, or (-) MDMA.

Department

Biological Sciences

Patent Number

US7858756; EP2032602 (B1); ES2415655 (T3)

Application Number

US20080125579

Application Published

5-29-2008

Application Filed

6-15-2007

Assignee

Board of Trustees of the University of Arkansas (Little Rock, AR)

Comments

GOVERNMENTAL RIGHTS This invention was made with government support under DA11560, DA14361, and DA05477 awarded by the National Institute on Drug Abuse. The government has certain rights in the invention.

Ralph Henry, Department of Biological Sciences

Citation

Owens, S. M., Gunnell, M., Chi, Y., Carroll, F. I., Henry, R., & Peterson, E. (2010). Monoclonal antibodies that selectively recognize methamphetamine and methamphetamine like compounds. Patents Granted. Retrieved from https://scholarworks.uark.edu/pat/75